Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone
US6984633B2 · kind B2 · utility
5Cited by
6References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2003 |
| Grant date | Jan 10, 2006 |
| Priority date | — |
| Expiry date | Feb 21, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic method is described for treating cardiofibrosis or cardiac hypertrophy using a combination therapy comprising a therapeutically-effective amount of an angiotensin II receptor antagonist and a therapeutically-effective amount of expoxymexrenone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.